Enochian Biosciences, Inc.
ENOB · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$178,007 | -$80,650 | -$39,684,056,000 | -$113,433 |
| Dep. & Amort. | $129 | $122 | $113,496,000 | $124 |
| Deferred Tax | $0 | $0 | -$3,894,955,000 | $0 |
| Stock-Based Comp. | $3,313 | $4,673 | $3,535,051,000 | $5,491 |
| Change in WC | $0 | $0 | $3,894,955,000 | $1,415 |
| Other Non-Cash | $166,690 | $64,884 | $24,260,960,000 | $90,672 |
| Operating Cash Flow | -$7,875 | -$10,971 | -$11,774,549,000 | -$15,732 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$70 | -$29,774,000 | -$5 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$500 | -$1,190 | $0 | $0 |
| Investing Cash Flow | -$500 | -$1,260 | -$29,774,000 | -$5 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $2,000 | $1,200,000,000 | $4,676 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $8,383 | $10,517 | $4,515,056,000 | $4,250 |
| Financing Cash Flow | $8,383 | $10,517 | $4,515,056,000 | $4,250 |
| Forex Effect | -$136 | $60 | -$8,395,000 | -$5 |
| Net Chg. in Cash | -$128 | -$1,654 | -$7,297,662,000 | -$11,492 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $220 | $1,874 | $9,172,142,000 | $20,664 |
| End Cash | $93 | $220 | $1,874,480,000 | $9,172 |
| Free Cash Flow | -$7,875 | -$11,042 | -$11,804,323,000 | -$15,737 |